Krebs Biochemicals and Industries Limited — Others, 15-05-2025: Disclosure under SEBI Takeover Regulations

Ipca Laboratories, promoters of Krebs Biochemicals & Industries Ltd., has confirmed that no encumbrance has been created on their equity shares for the financial year ending March 31, 2025. This means their shares remain free from any pledge or charge, providing clarity and security to shareholders and reinforcing confidence in the stability of the promoter’s holding.